Tactile Medical signs exclusive VA/DoD U.S. distribution deal for MyoSleeve with $3M upfront

Tactile Medical announced an exclusive U.S. distribution agreement for MyoSleeve with a $3.0M upfront payment.

Key Highlights:

• Entered exclusive distribution deal with ElastiMed to supply MyoSleeve to VA and DoD patients nationwide.
• Paid $3.0 million upfront and committed to minimum purchases plus marketing and sales promotion.
• MyoSleeve is FDA 510(k)-cleared for chronic swelling, including chronic edema, lymphedema, and venous insufficiency.
• Device is discreet, battery-powered, cable-free, wearable under clothing and intended for earlier-stage or complementary use.
• Company will leverage sales, billing, and patient support infrastructure to drive commercialization and market access.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.